Global Pancreatic Cancer Treatment Market

Global Pancreatic Cancer Treatment Market Size, Share, Growth Analysis, By Treatment Type(Chemotherapy, Targeted Therapy), By Diagnosis(Blood Test, Biopsy), By Route of Administration(Oral, Parenteral), By End-User(Hospitals, Specialty Clinics), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy) - Industry Forecast 2023-2030


Report ID: SQMIG35I2262 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: 149 | Figures: 78

Global Pancreatic Cancer Treatment Market Insights

Pancreatic Cancer Treatment Market size was valued at USD 2.15 billion in 2021 and is poised to grow from USD 2.48 billion in 2022 to USD 6.85 billion by 2030, growing at a CAGR of 15.7% in the forecast period (2023-2030).

Tumors are generally described as lumps of tissue that occur as a result of aberrant, uncontrolled cell proliferation. The pancreas cannot function normally when malignancies are present. The unchecked proliferation of cancerous cells, or in the tissues of the pancreas is known as pancreatic cancer. The pancreas develops tumours as a result of the cancerous cells, which prevents the organ from operating normally.
The pancreatic cancer treatment market is expected to expand quickly during the coming years. According to the American Cancer Society, pancreatic cancer makes up roughly 3% of all cancer cases in the United States (ACS). According to the American Cancer Society, around 33% of population suffered from pancreatic cancer in 2022. Due to its difficulty in detection, pancreatic cancer typically only becomes known when it has advanced to an advanced stage. Two signs of pancreatic cancer include jaundice and weight loss. Risk factors include having diabetes and being exposed to certain chemicals. Depending on the tumor size, location, and whether it has spread to other bodily areas, a certain treatment may be appropriate.

The market expansion is primarily the result of businesses restructuring their operations and recovering from the COVID-19 effect, which had previously occurred in restrictive containment measures like social isolation, remote work, and the closure of businesses that created operational difficulties.

US Pancreatic Cancer Treatment Market Market is poised to grow at a sustainable CAGR for the next forecast year.

To get more reports on the above market click here to Buy The Report

Global Pancreatic Cancer Treatment Market Segmental Analysis

Global pancreatic cancer treatment market is segmented on the basis of treatment type, diagnosis, route of administration, end-user, distribution channel, and region. Based on treatment type, the market is segmented into chemotherapy, targeted therapy, immunotherapy, hormone therapy, others.
 
Based on diagnosis, the market is segmented into blood test, biopsy, imaging tests, others. By route of administration, the market is segmented into oral, parenteral, and others. By end-user, the market is segmented into hospitals, specialty clinics, homecare, and others. By distribution channel, the market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, and others. Based on region, the pancreatic cancer treatment market segmentation spans North America, Europe, Asia-Pacific, South America, and MEA.

Pancreatic Cancer Treatment Market Analysis by Treatment Type
 
Targeted therapy dominated the market in 2022 and is expected to continue to do so during the forecast period. Targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells. The introduction of novel biologic therapies and targeted drugs to reduce the side effects of existing therapies, such as chemotherapy, is one of the factors driving growth.

To get detailed analysis on other segments, Request For Sample Report

Global Pancreatic Cancer Treatment Market Regional Insights

With the highest revenue share in 2022, North America dominated the pancreatic cancer treatment market. This region's dominance is primarily due to improved healthcare infrastructure, widespread adoption of pancreatic treatment procedures, and the presence of a large target population. Furthermore, the rising incidence of pancreatic cancer is driving up demand for treatment options. By authorising medications in the clinical phase and so hastening clinical advances, the USFDA is also taking steps to boost the development of the pancreatic cancer treatment market.

The market in Asia Pacific is expected to grow the fastest during the forecast period. The presence of well-established hospitals and critical care centers, as well as a large population suffering from pancreatic cancer, would drive the Asia Pacific market's growth. Furthermore, with the increasing number of pancreatic cancer cases in the Asia Pacific, pancreatic cancer diagnosis and treatment in the region must follow the same protocol as in Western countries. 

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Global Pancreatic Cancer Treatment Market Dynamics

Pancreatic Cancer Treatment Market Drivers

Rise in cases of cancer and need for ultra care is expected to accelerate the market growth

  • According to estimates, the market would develop faster due to the increased incidence of cancer. Genetic anomalies including the BRCA2 gene mutation, Lynch syndrome, and familial atypical mole-malignant melanoma (FAMMM) syndrome may increase the risk of cancer running in the family. The dynamics of the market will be impacted by the rising rates of diabetes and obesity, which will raise the risk of pancreatic cancer.
  • Increase in healthcare spending, which helps to improve its infrastructure, is a crucial element influencing the growth rate of the market for pancreatic cancer treatments. The market dynamics will be further impacted by various government organisations' efforts to strengthen the healthcare infrastructure by boosting funding.

Pancreatic Cancer Treatment Market Restraint

Significant costs of treatment and lack of healthcare infrastructure at remote locations to impede the market growth

  • The high cost of the treatment will impede the market expansion. The pancreatic cancer treatment market will face challenges due to a shortage of skilled workers and a lack of healthcare infrastructure in emerging nations. 
  • During the projection period of 2023–2030, rigorous regulatory rules and a lack of public awareness would further constrain and restrict the market's growth rate.

Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report

Global Pancreatic Cancer Treatment Market Competitive Landscape

The pancreatic cancer treatment market is fiercely competitive, and few major companies dominate it. The competition is getting more intense due to the presence of major market players. The market participants are implementing methods including increased R&D spending, mergers, acquisitions, and product developments.

Top Players in the Global Pancreatic Cancer Treatment Market

  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Celgene Corporation
  • Novartis AG
  • Pfizer Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Ipsen S.A.
  • Gilead Sciences, Inc.
  • Daiichi Sankyo Company, Limited
  • Boehringer Ingelheim International GmbH
  • Jazz Pharmaceuticals, Inc.
  • Exelixis, Inc

Pancreatic Cancer Treatment Market Recent Developments

  • In January 2022, for pancreatic cancer treatment, the U.S. Food and Drug Administration (FDA) gave orphan drug status to multitargeted T-cell therapy. This therapy has shown the potential to elicit sustained responses in individuals with advanced or metastatic pancreatic cancer when combined with chemotherapy as a first-line therapeutic option.

     

  • In February 2022, Eli Lilly and Company and UNICEF declared a collaboration aimed at improving healthcare facilities for around 10 million children and adolescents suffering from non-communicable diseases.

Global Pancreatic Cancer Treatment Key Market Trends

  • Increase in R&D activities: Rise in the R&D activities is fueling the market expansion. This will present advantageous chances for the expansion of the market for treatments for pancreatic cancer. Along with this, an increase in drug releases and approvals will speed up the market's expansion.

     

  • Increase in investments: Additionally, the growing investments in the creation of cutting-edge technologies and an increase in the quantity of emerging markets will create more favourable conditions for the expansion of the pancreatic cancer treatment market over the forecast period.

Global Pancreatic Cancer Treatment Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to the pancreatic cancer treatment market report analysis, by treatment, the targeted therapy segment has the largest revenue share in 2022. Region-wise, North America dominated the global market in terms of market share and size and is attributable to a dominant position owing to presence of established players and availability of state-of-the-art treatment.

Report Metric Details
Market size value in 2021 USD 2.15 billion
Market size value in 2030 USD 6.85 billion
Growth Rate 15.7%
Base year 2021
Forecast period 2023-2030
Forecast Unit (Value) USD Billion
Segments covered
  • Treatment Type
    • Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Others
  • Diagnosis
    • Blood Test, Biopsy, Imaging Tests, Others
  • Route of Administration
    • Oral, Parenteral, Others
  • End-User
    • Hospitals, Specialty Clinics, Homecare, Others
  • Distribution Channel
    • Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Celgene Corporation
  • Novartis AG
  • Pfizer Inc.
  • Amgen Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited
  • Ipsen S.A.
  • Gilead Sciences, Inc.
  • Daiichi Sankyo Company, Limited
  • Boehringer Ingelheim International GmbH
  • Jazz Pharmaceuticals, Inc.
  • Exelixis, Inc
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Global Pancreatic Cancer Treatment Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Global Pancreatic Cancer Treatment Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Global Pancreatic Cancer Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Pancreatic Cancer Treatment Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Pancreatic Cancer Treatment Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Global Pancreatic Cancer Treatment Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

SPEAK TO AN ANALYST

FAQ's

Pancreatic Cancer Treatment Market size was valued at USD 2.15 billion in 2021 and is poised to grow from USD 2.48 billion in 2022 to USD 6.85 billion by 2030, growing at a CAGR of 15.7% in the forecast period (2023-2030).

The pancreatic cancer treatment market is fiercely competitive, and few major companies dominate it. The competition is getting more intense due to the presence of major market players. The market participants are implementing methods including increased R&D spending, mergers, acquisitions, and product developments. 'Eli Lilly and Company', 'F. Hoffmann-La Roche Ltd.', 'Celgene Corporation', 'Novartis AG', 'Pfizer Inc.', 'Amgen Inc.', 'Merck & Co., Inc.', 'Bayer AG', 'Bristol-Myers Squibb Company', 'AstraZeneca', 'AbbVie Inc.', 'Teva Pharmaceutical Industries Ltd.', 'Sanofi S.A.', 'Takeda Pharmaceutical Company Limited', 'Ipsen S.A.', 'Gilead Sciences, Inc.', 'Daiichi Sankyo Company, Limited', 'Boehringer Ingelheim International GmbH', 'Jazz Pharmaceuticals, Inc.', 'Exelixis, Inc'

According to estimates, the market would develop faster due to the increased incidence of cancer. Genetic anomalies including the BRCA2 gene mutation, Lynch syndrome, and familial atypical mole-malignant melanoma (FAMMM) syndrome may increase the risk of cancer running in the family. The dynamics of the market will be impacted by the rising rates of diabetes and obesity, which will raise the risk of pancreatic cancer.

Increase in R&D activities: Rise in the R&D activities is fueling the market expansion. This will present advantageous chances for the expansion of the market for treatments for pancreatic cancer. Along with this, an increase in drug releases and approvals will speed up the market's expansion.  

With the highest revenue share in 2022, North America dominated the pancreatic cancer treatment market. This region's dominance is primarily due to improved healthcare infrastructure, widespread adoption of pancreatic treatment procedures, and the presence of a large target population. Furthermore, the rising incidence of pancreatic cancer is driving up demand for treatment options. By authorising medications in the clinical phase and so hastening clinical advances, the USFDA is also taking steps to boost the development of the pancreatic cancer treatment market.

Speak With Our Analyst

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pancreatic Cancer Treatment Market

Product ID: SQMIG35I2262

$5,300
BUY NOW GET SAMPLE